TY - JOUR
T1 - Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology
AU - Helb, Danica
AU - Jones, Martin
AU - Story, Elizabeth
AU - Boehme, Catharina
AU - Wallace, Ellen
AU - Ho, Ken
AU - Kop, Joann
AU - Owens, Michelle R.
AU - Rodgers, Richard
AU - Banada, Padmapriya
AU - Safi, Hassan
AU - Blakemore, Robert
AU - Ngoc Lan, N. T.
AU - Jones-López, Edward C.
AU - Levi, Michael
AU - Burday, Michele
AU - Ayakaka, Irene
AU - Mugerwa, Roy D.
AU - McMillan, Bill
AU - Winn-Deen, Emily
AU - Christel, Lee
AU - Dailey, Peter
AU - Perkins, Mark D.
AU - Persing, David H.
AU - Alland, David
PY - 2010/1
Y1 - 2010/1
N2 - Current nucleic acid amplification methods to detect Mycobacterium tuberculosis are complex, labor-intensive, and technically challenging. We developed and performed the first analysis of the Cepheid Gene Xpert System's MTB/RIF assay, an integrated hands-free sputum-processing and real-time PCR system with rapid on-demand, near-patient technology, to simultaneously detect M. tuberculosis and rifampin resistance. Analytic tests of M. tuberculosis DNA demonstrated a limit of detection (LOD) of 4.5 genomes per reaction. Studies using sputum spiked with known numbers of M. tuberculosis CFU predicted a clinical LOD of 131 CFU/ml. Killing studies showed that the assay's buffer decreased M. tuberculosis viability by at least 8 logs, substantially reducing biohazards. Tests of 23 different commonly occurring rifampin resistance mutations demonstrated that all 23 (100%) would be identified as rifampin resistant. An analysis of 20 nontuberculosis mycobacteria species confirmed high assay specificity. A small clinical validation study of 107 clinical sputum samples from suspected tuberculosis cases in Vietnam detected 29/29 (100%) smear-positive culture-positive cases and 33/39 (84.6%) or 38/53 (71.7%) smear-negative culture-positive cases, as determined by growth on solid medium or on both solid and liquid media, respectively. M. tuberculosis was not detected in 25/25 (100%) of the culture-negative samples. A study of 64 smear-positive culture-positive sputa from retreatment tuberculosis cases in Uganda detected 63/64 (98.4%) culture-positive cases and 9/9 (100%) cases of rifampin resistance. Rifampin resistance was excluded in 54/55 (98.2%) susceptible cases. Specificity rose to 100% after correcting for a conventional susceptibility test error. In conclusion, this highly sensitive and simple-to-use system can detect M. tuberculosis directly from sputum in less than 2 h.
AB - Current nucleic acid amplification methods to detect Mycobacterium tuberculosis are complex, labor-intensive, and technically challenging. We developed and performed the first analysis of the Cepheid Gene Xpert System's MTB/RIF assay, an integrated hands-free sputum-processing and real-time PCR system with rapid on-demand, near-patient technology, to simultaneously detect M. tuberculosis and rifampin resistance. Analytic tests of M. tuberculosis DNA demonstrated a limit of detection (LOD) of 4.5 genomes per reaction. Studies using sputum spiked with known numbers of M. tuberculosis CFU predicted a clinical LOD of 131 CFU/ml. Killing studies showed that the assay's buffer decreased M. tuberculosis viability by at least 8 logs, substantially reducing biohazards. Tests of 23 different commonly occurring rifampin resistance mutations demonstrated that all 23 (100%) would be identified as rifampin resistant. An analysis of 20 nontuberculosis mycobacteria species confirmed high assay specificity. A small clinical validation study of 107 clinical sputum samples from suspected tuberculosis cases in Vietnam detected 29/29 (100%) smear-positive culture-positive cases and 33/39 (84.6%) or 38/53 (71.7%) smear-negative culture-positive cases, as determined by growth on solid medium or on both solid and liquid media, respectively. M. tuberculosis was not detected in 25/25 (100%) of the culture-negative samples. A study of 64 smear-positive culture-positive sputa from retreatment tuberculosis cases in Uganda detected 63/64 (98.4%) culture-positive cases and 9/9 (100%) cases of rifampin resistance. Rifampin resistance was excluded in 54/55 (98.2%) susceptible cases. Specificity rose to 100% after correcting for a conventional susceptibility test error. In conclusion, this highly sensitive and simple-to-use system can detect M. tuberculosis directly from sputum in less than 2 h.
UR - http://www.scopus.com/inward/record.url?scp=73949120420&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=73949120420&partnerID=8YFLogxK
U2 - 10.1128/JCM.01463-09
DO - 10.1128/JCM.01463-09
M3 - Article
C2 - 19864480
AN - SCOPUS:73949120420
SN - 0095-1137
VL - 48
SP - 229
EP - 237
JO - Journal of Clinical Microbiology
JF - Journal of Clinical Microbiology
IS - 1
ER -
